首页> Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association> The effectiveness of vedolizumab in advanced therapy-experienced ulcerative colitis patients: Real world data from the Inflammatory Bowel Disease of the Middle East (IBD-ME) Registry group.

The effectiveness of vedolizumab in advanced therapy-experienced ulcerative colitis patients: Real world data from the Inflammatory Bowel Disease of the Middle East (IBD-ME) Registry group.

导出 OA

翻译打印收藏纠错

第一作者： Nahla,Azzam

第一单位： Department of Medicine, Division of Gastroenterology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

作者： Nahla,Azzam ^[1] ; Othman,Alharbi ^[1] ; Mansour,Altuwaijri ^[1] ; Yazed,Alruthia ^[2] ; Heba,Alfarhan ^[3] ; Suliman,Alshankiti ^[1] ; Faris,Nafisah ^[1] ; Qusay,Ajlan ^[1] ; Abdulrahman,Aljebreen ^[1] ; Majid,Almadi ^[4] ; Mahmoud H,Mosli ^[5]

作者单位： Department of Medicine, Division of Gastroenterology, College of Medicine, King Saud University, Riyadh, Saudi Arabia. ^[1] Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.;Department of Clinical Pharmacy, Pharmacoeconomics Research Unit, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. ^[2] Department of Internal Medicine, Division of Gastroenterology, Thunayan Al Ghanim Gastroenterology Center at Al Amiri Hospital, Kuwait City, Kuwait. ^[3] Department of Medicine, Division of Gastroenterology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.;Department of Medicine, Division of Gastroenterology, The McGill University Health Center, Montreal General Hospital, McGill University, Montreal, Canada. ^[4] Department of Internal Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.;Inflammatory Bowel Disease Unit, King Abdulaziz University Hospital, Jeddah, Saudi Arabia. ^[5]